Marinus Pharmaceuticals (MRNS)
(Real Time Quote from BATS)
$1.47 USD
+0.04 (2.80%)
Updated Jul 22, 2024 01:04 PM ET
4-Sell of 5 4
F Value F Growth C Momentum F VGM
Earnings News For MRNS
-
Marinus Pharmaceuticals (MRNS) Reports Q1 Loss, Lags Revenue Estimates
-
Marinus Pharmaceuticals: Q1 Earnings Snapshot
-
Marinus Pharmaceuticals Provides Business Update and Reports First Quarter 2024 Financial Results
-
Marinus Pharmaceuticals Provides Update on the Phase 3 RAISE Trial and Reports Preliminary First Quarter 2024 Financial Results
-
Marinus Pharmaceuticals: Q4 Earnings Snapshot
-
Marinus Pharmaceuticals (MRNS) Reports Q4 Loss, Lags Revenue Estimates
-
Marinus Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results
-
Marinus Pharmaceuticals Reports Preliminary Fourth Quarter and Full Year 2023 ZTALMY? Net Product Revenue and Provides Business Update
-
Marinus Pharmaceuticals: Q3 Earnings Snapshot
-
Marinus Pharmaceuticals Provides Business Update and Reports Third Quarter 2023 Financial Results
-
Marinus Pharmaceuticals (MRNS) Reports Q2 Loss, Tops Revenue Estimates
-
Marinus Pharmaceuticals: Q2 Earnings Snapshot
-
Marinus Pharmaceuticals Provides Business Update and Reports Second Quarter 2023 Financial Results
-
Marinus Pharmaceuticals (MRNS) Reports Q1 Loss, Tops Revenue Estimates
-
Marinus Pharmaceuticals: Q1 Earnings Snapshot
-
Marinus Pharmaceuticals Provides Business Update and Reports First Quarter 2023 Financial Results
-
Earnings Preview: Marinus Pharmaceuticals (MRNS) Q1 Earnings Expected to Decline
-
Marinus Pharmaceuticals: Q4 Earnings Snapshot
-
Marinus Pharmaceuticals (MRNS) Reports Q4 Loss, Misses Revenue Estimates
-
Marinus Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Full Year 2022 Financial Results
-
Marinus Pharmaceuticals Reports Preliminary Fourth Quarter and Full Year 2022 ZTALMY? Net Product Revenue and Provides Business Update
-
Marinus Pharmaceuticals (MRNS) Reports Q3 Loss, Misses Revenue Estimates
-
Marinus Pharmaceuticals: Q3 Earnings Snapshot
-
Marinus Pharmaceuticals Provides Business Update and Reports Third Quarter 2022 Financial Results
-
Marinus Pharmaceuticals (MRNS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release